Los puntos clave no están disponibles para este artículo en este momento.
In summary, these results demonstrated that CD47/SIRPα blocking peptides, pep-20 and its derivate, could serve as promising candidates to promote macrophages-mediated phagocytosis and immune response in cancer immunotherapy.
Wang et al. (Thu,) studied this question.